Name | DHODH-IN-11 |
---|
Description | DHODH-IN-11 (Compound 14b) is a Leflunomide derivative and a weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.03[1]. |
---|---|
Related Catalog | |
Target |
pKa: 5.03 (DHODH)[1] |
In Vitro | Designed a compound structurally related to Leflunomide, containing the furazan ring (Compound 14a), is designed. Compound 14a undergo ring 4 scission under physiological pH conditions to afford the corresponding cyano-oximes DHODH-IN-11 (Compound 14b). DHODH-IN-14 has been assayed as a DHODH inhibitor; its low potency is probably due to the unfavourable stereochemistry of the oxime substructure[1]. |
References |
Molecular Formula | C15H11N3O2 |
---|---|
Molecular Weight | 265.27 |
Hazard Codes | Xi |
---|